摘要
小金丸源于《外科证治全生集》,原名"小金丹",为治疗痈疡经典名方,临床上治疗乳腺增生首选中成药。该文针对有关小金丸的文献报道进行归纳总结,对其历史沿革、物质基础、药理作用、质量控制等问题进行系统梳理,探究发展现状中各环节潜在问题,提出发展对策,为小金丸的现代化研究与开发提供参考。
Xiaojin Pill,was firstly recorded in Life-saving Manual of Diagnosis and Treatment of External Diseases,with its primitive name of " Xiaojin Dan". Xiaojin Pill is a classic prescription for treating carbuncle and it is the first choice for Chinese medicine in the clinical treatment of hyperplasia of mammary glands. In this paper,the literature reports on Xiaojin Pills were summarized and the historical evolution,material basis,pharmacological action,quality control and other problems were systematically discussed to explore the potential problems in every aspect of the development status,and put forward the development countermeasures,providing reference for the modernization research and development of Xiaojin Pills.
作者
熊茜
冯碧
曹波
张定堃
熊开鹏
林俊芝
慈志敏
许润春
韩丽
XIONG Xi;FENG Bi;CAO Bo;ZHANG Ding-kun;XIONG Kai-peng;LIN Jun-zhi;CI Zhi-min;XU Run-chun;HAN Li(State Key Laboratory,Breeding Base of Systematic Research,Development and Utilization of Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine,Chengdu 611137,China;Chengdu Jiuzhitang Jinding Pharmaceutical Co.,Ltd.,Chengdu 610051,China;Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072,China)
出处
《中国中药杂志》
CAS
CSCD
北大核心
2018年第24期4801-4807,共7页
China Journal of Chinese Materia Medica
基金
国家自然科学基金项目面上项目(81274098)
成都中医药大学中药学学科特色创新科研团队项目(CXTD2018006)
成都中医药大学附属医院院基金项目(2017-D-YY-46)
关键词
小金丸
化学成分
药理作用
质量控制
临床应用
粒子设计
Xiaojin Pills
chemical components
pharmacological action
quality control
clinical application
particle design
